Uncategorized
FDA approves Travere’s Filspari as first drug for the kidney disease called FSGS
FDA approves Travere’s Filspari as first drug for the kidney disease called FSGS
The FDA expanded the label for Filspari on Monday to add another kidney condition. The drug is now the first therapy approved in the US for focal segmental glomerulosclerosis (FSGS).
The pill may be taken … Read More